For the year ending 2026-03-31, PBH had -$34,016K decrease in cash & cash equivalents over the period. $246,449K in free cash flow.
| Cash Flow | 2026-03-31 |
|---|---|
| Net income | 190,301 |
| Depreciation and amortization | 31,273 |
| Loss on sale or disposal of property and equipment | -165 |
| Deferred and other income taxes | 22,697 |
| Amortization of debt origination costs | 1,797 |
| Stock-based compensation costs | 10,835 |
| Non-cash operating lease cost | 7,850 |
| Write-off of supplier loan | 10,332 |
| Impairment loss | 0 |
| Other Noncash Income Expense | 0 |
| Accounts receivable | 3,685 |
| Inventories | 1,597 |
| Prepaid expenses and other current assets | 6,968 |
| Accounts payable | -151 |
| Accrued liabilities | 2,527 |
| Operating lease liabilities | -7,781 |
| Increase Decrease In Other Noncurrent Assets And Liabilities Net | -32 |
| Net cash provided by operating activities | 257,627 |
| Purchases of property, plant and equipment | 11,178 |
| Acquisitions, net of cash acquired | 123,736 |
| Other | 1,927 |
| Net cash used in investing activities | -136,841 |
| Term loan repayments | 0 |
| Borrowings under revolving credit agreement | 40,000 |
| Repayments under revolving credit agreement | 40,000 |
| Net increase in line of credit | 2,986 |
| Payment of debt costs | 0 |
| Payments of finance leases | 2,482 |
| Proceeds from exercise of stock options | 4,285 |
| Fair value of shares surrendered as payment of tax withholding | 4,322 |
| Repurchase of common stock | 156,283 |
| Other | -246 |
| Net cash used in financing activities | -156,062 |
| Effects of exchange rate changes on cash and cash equivalents | 1,260 |
| (decrease) increase in cash and cash equivalents | -34,016 |
| Cash and cash equivalents - beginning of year | 97,884 |
| Cash and cash equivalents - end of year | 63,868 |
Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (PBH)